World Library  
Flag as Inappropriate
Email this Article

Controlled Drugs and Substances Act

 

Controlled Drugs and Substances Act

The Controlled Drugs and Substances Act is Canada's federal drug control statute. Passed in 1996 by the Chrétien government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drug Act and establishes eight Schedules of controlled substances and two Classes of precursors. It provides that "The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest."

The Act serves as the implementing legislation for the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

Contents

  • (Incomplete) List of Drugs 1
    • Schedule I 1.1
    • Schedule II 1.2
    • Schedule III 1.3
    • Schedule IV 1.4
    • Schedule V 1.5
    • Schedule VI (Precursors) 1.6
  • Laws 2
    • Possession 2.1
    • Trafficking/Possession for the Purpose of 2.2
    • Exportation/Possession for the Purpose of 2.3
    • Production 2.4
  • Amendments to the act 3
  • See also 4
  • References 5
  • External links 6

(Incomplete) List of Drugs

A complete list of drugs scheduled in Canada's Controlled Drugs and Substances Act can be found here. This list is what is reflected below. Some less common chemicals are omitted.

On March 12, 2012, controversial Bill C-10, the Safe Streets and Communities Act was passed into law. Amphetamines and their isomers, derivatives, and analogues, including MDA and MDMA (Ecstasy), as well as potential "date rape drugs" Rohypnol and GHB were rescheduled from Schedule III to Schedule I. Dealers of Schedule I drugs now face mandatory minimum sentencing of 1 year imprisonment. Also, the rescheduling imposes harsher punishment for possession.

Schedule I

  • Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:
  1. Opium
  2. Codeine (methylmorphine)
  3. Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)
  4. Thebaine (paramorphine)

and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:

  1. Acetorphine (acetyletorphine)
  2. Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)
  3. Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)
  4. Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)
  5. Desomorphine (dihydrodeoxymorphine)
  6. Diacetylmorphine (heroin)
  7. Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)
  8. Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)
  9. Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)
  10. Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)
  11. Hydrocodone (dihydrocodeinone)
  12. Hydromorphinol (dihydro–14–hydroxymorphine)
  13. Hydromorphone (dihydromorphinone)
  14. Methyldesorphine (Δ6–deoxy–6–methylmorphine)
  15. Methyldihydromorphine (dihydro–6–methylmorphine)
  16. Metopon (dihydromethylmorphinone)
  17. Morphine–N–oxide (morphine oxide)
  18. Myrophine (benzylmorphine myristate)
  19. Nalorphine (N–allylnormorphine)
  20. Nicocodine (6–nicotinylcodeine)
  21. Nicomorphine (dinicotinylmorphine)
  22. Norcodeine (N–desmethylcodeine)
  23. Normorphine (N–desmethylmorphine)
  24. Oxycodone (dihydrohydroxycodeinone)
  25. Oxymorphone (dihydrohydroxymorphinone)
  26. Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)
  27. Thebacon (acetyldihydrocodeinone)

but not including

  1. Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol)
  2. Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine)
  3. Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol)
  4. Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one)
  5. Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one)
  6. Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone)
  7. Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline)
  8. Poppy seed
    • Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:
    1. Coca leaves
    2. Cocaine (benzoylmethylecgonine)
    3. Ecgonine (3–hydroxy–2–tropane carboxylic acid)
    • Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:
    1. Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)
    2. Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
    3. Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
    4. Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)
    5. Betameprodine (ß–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
    6. Betaprodine (ß–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
    7. Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)
    8. Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
    9. Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
    10. Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)
    11. Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)
    12. Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)
    13. Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)
    14. Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)
    15. Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)
    16. Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)
    17. Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)
    18. Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)
    19. Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)
    20. Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)
    21. Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)
    22. Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate)

    but not including

    1. Carbamethidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate)
    2. Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate)
    • Phenazepines, their salts, derivatives and salts of derivatives including:
    1. Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate)

    but not including

    1. Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate)
    2. Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate)
    3. Metheptazine (ethyl hexahydro–1,2–dimethyl–4–phenylazepine–4–carboxylate)
    • Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
    1. Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)
    2. Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)
    3. Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)
    4. Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)
    5. Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)
    6. Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)
    7. Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)
    • Methadols, their salts, derivatives and salts of derivatives including:
    1. Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
    2. Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
    3. Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)
    4. Betacetylmethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
    5. Betamethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol)
    6. Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)
    7. Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)
    • Phenalkoxams, their salts, derivatives and salts of derivatives including:
    1. Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)
    2. Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)
    3. Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)
    • Thiambutenes, their salts, derivatives and salts of derivatives including:
    1. Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)
    2. Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)
    3. Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)
    • Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
    1. Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
    2. Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)
    3. Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
    4. Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)
    • Morphinans, their salts, derivatives and salts of derivatives including:
    1. Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)
    2. Drotebanol (6ß,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)
    3. Levomethorphan (l–3–methoxy–17–methylmorphinan)
    4. Levorphanol (l–3–hydroxy–17–methylmorphinan)
    5. Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)
    6. Norlevorphanol (l–3–hydroxymorphinan)
    7. Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)
    8. Racemethorphan (d,1–3–methoxy–17–methylmorphinan)
    9. Racemorphan (d,l–3–hydroxy–N–methylmorphinan)

    but not including

    1. Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren)
    2. Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol)
    3. Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)
    4. Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)
    5. Butorphanol (17–(cyclobutylmethyl)morphinan–3,14–diol)
    6. Nalbuphine (17–(cyclobutylmethyl)–4,5α–epoxymorphinan–3,6α, 14–triol)
    • Benzazocines, their salts, derivatives and salts of derivatives including:
    1. Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)
    2. Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)
    3. Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol)

    but not including

    1. Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol)
    • Ampromides, their salts, derivatives and salts of derivatives including:
    1. Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)
    2. Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)
    3. Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)
    • Benzimidazoles, their salts, derivatives and salts of derivatives including:
    1. Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
    2. Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
    3. Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine)
    • Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
    1. Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)
    • Piritramide (1–(3–cyano–3,3–diphenylpropyl)–4–(1–piperidino)piperidine–4–carboxylic acid amide), its salts, derivatives and salts of derivatives
    • Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:
    1. Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)
    2. Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)
    3. Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)
    4. p–Fluorofentanyl (4′fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)
    5. Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)
    6. ß–Hydroxyfentanyl (N–[1–(ß–hydroxyphenethyl)–4–piperidyl] propionanilide)
    7. ß–Hydroxy–3–methylfentanyl (N–[1–(ß–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)
    8. α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)
    9. α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
    10. 3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)
    11. 3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
    12. Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
    13. Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
    14. Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
      • Tilidine (ethyl2–(dimethylamino)–1–phenyl–3–cyclohexene–1–carboxylate), its salts, derivatives and salts of derivatives
      1. Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
      • Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
      • Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
      1. Amphetamine (α-methylbenzene-ethanamine)
      2. N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
      3. 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
      4. 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
      5. 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
      6. 4-methoxyamphetamine (4-methoxy-α-methylbenzene­ethanamine)
      7. 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzene­ethanamine)
      8. N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
      9. 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
      10. 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzo­dioxole-5-ethanamine)
      11. N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
      12. N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzo­dioxole-5-ethanamine)
      13. 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
      14. 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
      15. 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
      16. 4-ethoxyamphetamine (4-ethoxy-α-methylbenzene­ethanamine)
      17. Benzphetamine (N-benzyl-N,α-dimethylbenzene­ethanamine)
      18. N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzo­dioxole-5-ethanamine)
      19. N-(2-Hydroxyethyl)-α-meth-ylbenzene­ethanamine
      20. N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxyla­mine)
      21. 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzene­ethanamine)
      • Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives 4-hydroxybutanoic acid (GHB) and any of its salts

      Schedule II

      • Cannabis, its preparations, derivatives and similar synthetic preparations.
        • including:
          • Cannabidiol (2–[3–methyl–6–(1–methylethenyl)–2–cyclohexen–1–yl]–5–pentyl–1,3–benzenediol)
          • Cannabinol (3–n–amyl–6,6,9–trimethyl–6–dibenzopyran–1–ol)
          • Nabilone ((±)–trans–3–(1,1–dimethylheptyl)–6,6a, 7,8,10,10a–hexahydro–1–hydroxy–6,6–dimethyl–9H–dibenzo[b,d]pyran–9–one)
          • Pyrahexyl (3–n–hexyl–6,6,9–trimethyl–7,8,9, 10–tetrahydro–6–dibenzopyran–1–ol)
          • Tetrahydrocannabinol (tetrahydro–6,6,9–trimethyl–3–pentyl–6H–dibenzo[b,d]pyran–1–ol)
          • 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
        • but not including:
          • Non–viable Cannabis seed, with the exception of its derivatives
          • Mature Cannabis stalks that do not include leaves, flowers, seeds or branches; and fiber derived from such stalks

      Schedule III

      1. [Repealed, 2012, c. 1, s. 45]
      2. Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof
      3. Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof
      4. Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
      5. LSD (Lysergic acid diethylamide) (N,N–diethyllysergamide) and any salt thereof
      6. DET (N,N–Diethyltryptamine) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
      7. DMT (N,N–Dimethyltryptamine) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
      8. N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
      9. Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
      10. Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
      11. Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
      12. Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
      13. PCE (N–(1–phenylcyclohexyl)ethylamine) and any salt thereof
      14. TCP (1–[1–(2–Thienyl) cyclohexyl]piperidine) and any salt thereof
      15. PCPr (1–Phenyl–N–propylcyclohexanamine) and any salt thereof
      16. Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
      17. Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
      18. 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof
      19. Cathinone ((–)–α–aminopropiophenone) and any salt thereof
      20. Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
      21. Methcathinone (2–Methylamino–1–phenyl–1–propanone) and any salt thereof
      22. Benzylcyclidine (1–[1–(Phenylmethyl)cyclohexyl]piperidine) and any salt thereof
      23. 4-methyl-PCP (1–[1–(4–Methylphenyl)cyclohexyl]piperidine) and any salt thereof
      24. 2C-B (4–bromo–2,5–dimethoxybenzeneethanamine) and any salt, isomer or salt of isomer thereof
      25. and 26. [Repealed, 2012, c. 1, s. 46]
      26. [Repealed, 2012, c. 1, s. 46]
      27. Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
      28. Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
      29. Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof
      30. Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
      31. Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
      32. Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
      33. BZP (Benzylpiperazine) (1-benzylpiperazine) and its salts, isomers and salts of isomers
      34. TFMPP (Trifluoromethylphenylpiperazine) (1-(3-trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers

      Schedule IV

      Schedule V

      Schedule VI (Precursors)

      Laws

      Possession

      If treated as an indictable offence, the penalty is:

      Schedule I: Maximum 7 years imprisonment
      Schedule II: (exceeding amounts set in Schedule VIII): Maximum 5 years imprisonment
      Schedule III: (Requires a prescription or license to legally possess.) Maximum 3 years imprisonment
      Schedule IV: It is not an offence to possess a Schedule IV substance for personal use; however, Subsection (2) of Section (4) of the CDSA states that "no person shall seek or obtain a substance or authorization from a practitioner to obtain a substance in schedules I through IV." unless the person discloses to the practitioner particulars relating to the acquisition by the person of every substance in those Schedules, and of every authorization to obtain such substances, from any other practitioner within the preceding thirty days. Subsection (7) then states that it is an indictable offence to contravene subsection (2). Therefore, it is an indictable offence to attempt to acquire a Schedule IV substance but not an offence for possession. Section 5 provides that possession for the purpose of trafficking of a Schedule IV substance is an offence.

      If treated as a summary conviction offence, the penalty is:

      Maximum $1000 fine for first offence and/or maximum 6 months imprisonment.
      Maximum $2000 fine for subsequent offence and/or maximum 1 year imprisonment.

      Note: For amounts not exceeding those set in Schedule VIII, maximum fine of $1000 and/or maximum 6 months imprisonment is the only punishment.

      Trafficking/Possession for the Purpose of

      If tried as an indictable offence, the defendant is liable to:

      Schedule I or Schedule II (exceeding amounts set in Schedule VII): Maximum life imprisonment

      • Mandatory minimum 1 year jail sentence for trafficking a Schedule I drug under 1 kg, 2 years if amount exceeds 2 kg

      Schedule II (not exceeding amounts set in Schedule VII): Maximum 5 years imprisonment
      Schedule III: Maximum 10 years imprisonment
      Schedule IV: Maximum 3 years imprisonment

      Or, if tried as a summary conviction, the defendant is liable to:

      Schedule III: Maximum 18 months imprisonment
      Schedule IV: Maximum 1 year imprisonment

      Exportation/Possession for the Purpose of

      If tried as an indictable offence, the defendant is liable to:

      Schedule I or Schedule II: Maximum life imprisonment
      Schedule III or Schedule IV: Maximum 10 years imprisonment
      Schedule V or Schedule VI: Maximum 3 years imprisonment

      Or, if tried as a summary conviction, the defendant is liable to:

      Schedule III or Schedule IV: Maximum 18 months imprisonment
      Schedule V or Schedule VI: Maximum 1 year imprisonment

      Production

      If tried as an indictable offence, the defendant is liable to:

      Schedule I or Schedule II (excluding cannabis): Maximum life imprisonment
      Cannabis: Maximum 7 years imprisonment
      Schedule III: Maximum 10 years imprisonment
      Schedule IV: Maximum 3 years imprisonment

      Or, if tried as a summary conviction, the defendant is liable to:

      Schedule III: Maximum 18 months imprisonment
      Schedule IV: Maximum 1 year imprisonment

      Amendments to the act

      In November 2007, the Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties imposed on those who commit drug offenses. On February 27, 2009 bill C-15, a re-introduction of C-26 received first reading in the 2nd Session of the 40th Parliament of Canada.[1] On June 9, 2009, the House of Commons passed Bill C-15, and it is now awaiting study and approval by the Senate. On December 14, 2009, the Senate passed Bill C-15, with some amendments, for approval by the House of Commons. When the Canadian Parliament dissolved in a prorogation on January 31, 2010, Bill C15, along with all legislation on the table, fell. However it will be reintroduced when parliament resumes with a new session in March. In the official press release they explain "...We will reintroduce in their original form the consumer safety law (Bill C-6) and the anti-drug-crime law (Bill C-15).... We will seek Opposition agreement to proceed expeditiously with other Government legislation -- particularly laws urgently needed to fight crime...."

      The current session of parliament passed Bill C-10 early in 2012, receiving Royal Assent in March. The final legislation sees changes made to four areas of the CDSA, outlining mandatory minimum sentences for offences relating to the trafficking and production of various controlled substances. Mandatory minimum sentencing does not apply to simple possession and trafficking in smaller amounts.

      See also

      References

      http://www.parl.gc.ca/LegisInfo/BillDetails.aspx?Language=E&Mode=1&billId=5120829&View=0

      1. ^ "Bill C-15: An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts". 

      External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.